Início › Sarcoma de Tecido Mole › Texas
Ensaios clínicos de Sarcoma de Tecido Mole em Texas
38 estudos para Sarcoma de Tecido Mole estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07189871Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
- UT MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06498648DESTINY-PANTUMOUR04
- Research Site, Dallas
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
- Baylor College of Medicine, Houston
RecrutandoFase 1/2
Até 25 anos · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04094610Anti-GD2 ADC M3554 in Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06641908A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07705334First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- University Of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06797999Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT05732831Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- UT MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades de 12 a 85 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT03715933Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- UT MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT05711615A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06760819Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05334069Actinium Therapy for Late-stage Aggressive Sarcomas
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07156565STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
- NEXT Dallas, Irving
- e mais 2
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06975293Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT01772771Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
- MD Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07283731T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 12 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06474676Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
- Ut Southwestern Medical Center, Dallas
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07139990Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
- M D Anderson Cancer Center, Houston
Recrutando
Idades 10 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT04199026A Study of MGC026 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
- The University of Texas M. D. Anderson Cancer Center, Houston
RecrutandoFase 1
Idades de 1 a 30 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07444619IDOV-Immune for Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics, San Antonio
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06910657Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- MD Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT07377747Lead-212 PSV359 Therapy for Patients With Solid Tumors
- MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades de 18 a 90 · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT06710756Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT04771520A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT06789172A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 27 de mai. de 2026 · NCT03093116Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
- M.D. Anderson Children's Cancer Hospital, Houston
RecrutandoFase 2
Idades de 8 a 30 · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT05726383SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
- The University of Texas M. D. Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT07049848A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT04969835Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
- William Beaumont Army Medical Center, Fort Bliss
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT06129903Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- M D Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT04693377Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's Health Dallas, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades de 2 a 30 · Todos os sexos · Atualizado em 3 de fev. de 2026 · NCT05734066HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- Texas Children's Hospital, Houston
RecrutandoFase 1
Idades de 1 a 25 · Todos os sexos · Atualizado em 22 de jan. de 2026 · NCT04995003cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de dez. de 2025 · NCT06943521A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Mary Crowley Cancer Research, Dallas
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT04370587BostonGene and Exigent Genomic INsight Study
- Oncology Consultants, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 17 de fev. de 2025 · NCT06272864Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.